Progesterone Levels and Pregnancy Results

The Effect of Maternal Serum and Amniotic Fluid Progesterone Levels on Pregnancy Results

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04400149

Enrollment

100

Registered

2020-05-22

Start date

2021-12-01

Completion date

2022-11-20

Last updated

2021-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Complications, Pregnancy Loss, Pregnancy Preterm

Brief summary

The aim of this study is to evaluate the amniotic fluid and serum progesterone level and pregnancy outcome

Detailed description

Studies have investigated the relationship between maternal serum progesterone level and low birth weight baby birth, hypertensive disorders of pregnancy, and early pregnancy bleeding. In some cases, patients are supported by oral or vaginal progesterone treatments during pregnancy. We also measure the relationship between maternal serum progesterone by measuring the level of amnion progesterone; We aimed to analyze the effects on pregnancy outcomes by observing preterm birth, premature rupture of membranes, low birth weight, baby gender, maternal problems that may occur during pregnancy, fetal problems.

Interventions

DIAGNOSTIC_TESTamniocentesis

amniocentesis will be performed to the pregnant women at 16-20 weeks who had a high-risk antenatal test. Furthermore, these women also give a blood sample (at 16-20 weeks) to compare the amniotic fluid and serum progesterone levels in association with pregnancy outcomes. We perform amniocentesis to evaluate genetic disorders in pregnant women who had his risk in the antenal test.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* Singleton pregnancy * Women who did not receive progesterone treatment during pregnancy

Exclusion criteria

* Women who receive progesterone treatment during pregnancy * multiple pregnancies * Diagnosed hypertension, diabetes mellitus, kidney disease, heart disease, liver disease

Design outcomes

Primary

Measure	Time frame	Description
pregnancy outcome	starting from 16 weeks, ending at the delivery of the baby	premature membran rupture Web sonuçları Premature Rupture of Membranes

Secondary

Measure	Time frame	Description
fetal outcomes	starting from 16 weeks, ending at the delivery of the baby	low birth weight

Contacts

Primary Contacttufan arslanca, M.D.

drtufanarslanca@hotmail.com+905324580546

Backup Contactbanu arslanca, M.D.

dr.banubozkurt@hotmail.com+90 532 253 80 13

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026